An Integrated Self-Management Intervention for Adolescents With Polycystic Ovary Syndrome

Sponsor
University of Texas at Austin (Other)
Overall Status
Completed
CT.gov ID
NCT03600337
Collaborator
Fordham University (Other), National Institute of Nursing Research (NINR) (NIH)
56
1
2
21.6
2.6

Study Details

Study Description

Brief Summary

Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder, affecting 7%-18% of reproductive-age women. Women with PCOS are at increased risk for a number of adverse physical and mental health outcomes. Often diagnosed during the challenging developmental period of adolescence (ages 14-18), current clinical practice guidelines fail to consider the life-long nature of effective PCOS self-management through sustained healthy lifestyle habits and may, in fact, contribute to maladaptive patterns of unsustainable strategies for weight loss in adolescents. The investigators are testing an integrated mindfulness-based healthy lifestyle intervention for adolescents with PCOS (Working to Optimize Wellness in Teens with PCOS [WOW]). The purpose of this study is to obtain data supporting preliminary efficacy of WOW on biological and mental health outcomes with adolescents diagnosed with PCOS.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Working to Optimize Wellness in Tees with PCOS (WOW)
N/A

Detailed Description

Innovative approaches to addressing the unique physical and mental health needs of adolescents with PCOS are needed. In response to this need, the investigators have developed an integrated mindfulness-based healthy lifestyle intervention for adolescents with PCOS (Working to Optimize Wellness in Teens with PCOS [WOW] through an iterative process of serial focus groups with adolescents and parents of adolescents with PCOS guided by the Individual and Family Self-Management Theory (IFSMT). In this pilot randomized control trial (RCT), 40 adolescents aged 14-18 years will be recruited to participate in the 5-week Working to Optimize Wellness in Teens with PCOS (WOW) intervention (N=20) or a waitlist-control condition (n=20). All participants will receive treatment as usual. Participants will meet weekly for 75-90 minutes for five weeks. Data collection will occur at 3 time points: Baseline data (T1) will be collected from all participants immediately following the informed consent process, Time 2 (T2) data will be collected immediately post-intervention, and Time 3 (T3) data will be collected one-month post-intervention. The waitlist- control condition will receive the intervention immediately following the one-month post-intervention data collection period. Following completion of the self-report measures at T3, individual exit interviews will be conducted with a subset of participants (N=10) from the WOW condition.

The primary aims of this research study are:
  1. To conduct a pilot RCT with 40 adolescents (ages 14-18) diagnosed with PCOS comparing WOW (n=20) to a wait-list control condition (n=20), and conduct individual exit-interviews to further refine WOW. The investigators expect to determine:
  1. Preliminary effects of WOW vs. wait-list control on blood pressure, fasting insulin, hemoglobin A1C, nutrition self-efficacy, physical activity, medication adherence, psychological well-being (i.e., depressive/anxiety symptoms, perceived stress, self-esteem) and health related quality of life.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
An Integrated Self-Management Intervention for Adolescents With Polycystic Ovary Syndrome
Actual Study Start Date :
Jun 15, 2018
Actual Primary Completion Date :
Apr 1, 2020
Actual Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Condition

Working to Optimize Wellness in Teens with PCOS

Behavioral: Working to Optimize Wellness in Tees with PCOS (WOW)
5 week, 75 minutes weekly, integrated mindfulness-based mental and physical health promotion intervention

No Intervention: Control Condition

Participants in this arm will receive treatment as usual and will be given the intervention after 1 month assessments are completed for the intervention group

Outcome Measures

Primary Outcome Measures

  1. Change in psychological distress [Immediately post-intervention]

    The Depression, Anxiety, and Stress Scale is a 21-item standardized scale that assess symptoms of depression, anxiety, and perceived stress. Participants rate each item from 0=Did not apply to me at all to 3=Applied to me very much or most of the time. All items are summed for a possible range from 0-63 with higher scores indicating higher levels of psychological distress.

  2. Change in health related quality of life [Immediately post-intervention]

    The Child Health Questionnaire-Child Self-Report Form is an 87-item measure consisting of 12 summed subscales assessing unique physical and psychosocial domains. Items are scored from 0 to 100 with higher scores indicating better quality of life

Secondary Outcome Measures

  1. Change in Diet self-efficacy [Immediately post-intervention, 1-month post-intervention]

    The Diet Self-Efficacy Scale is an 11-item standardized measure assessing self-efficacy for healthy nutrition choices in three domains, (a) high caloric food temptation, (b) social and internal factors, and (c) negative emotional events. For each item, participants select their level of confidence from 0=Not at all confident to 4= Very confident. Item scores are summed for a possible score range from 0 (very little diet self-efficacy) to 44 (very high diet self-efficacy).

  2. Change in Physical activity self-efficacy [Immediately post-intervention, 1-month post-intervention]

    The PACE Adolescent Physical Activity Survey is a 50-item standardized measure that assesses adolescents' stage of change, self-efficacy, family support, and peer support for physical activity. Self-efficacy is assessed with 7 items rated from 1=I'm sure I can't to 5=I'm sure I can. The mean of these 7 items will be used to assess physical activity self-efficacy immediately post-intervention and again at 1-month post-intervention with a possible score range from 1 to 7 and higher scores indicating higher self-efficacy for physical activity.

  3. Change in self-esteem [Immediately post-intervention]

    The Rosenberg Self-Esteem Scale is a 10-item scale that measures an individual's self-esteem. Participants rate each item from 3=Strongly Agree to 0=Strongly Disagree. Scores for the 10 items are summed for a possible score from 0 to 40 with higher scores indicating higher self-esteem.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 23 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adolescent age 14-23 years,

  • diagnosis of PCOS, OR obesity AND secondary amenorrhea, OR excessive and frequent menstruation and

  • ability to provide informed consent.

Exclusion Criteria:
  • inability to commit to attending all intervention sessions

  • unable to provide written informed consent/assent

  • loss of a loved one within the last year, or

  • history of post-traumatic stress disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas at Austin Austin Texas United States 78712

Sponsors and Collaborators

  • University of Texas at Austin
  • Fordham University
  • National Institute of Nursing Research (NINR)

Investigators

  • Principal Investigator: Cara C Young, PhD, University of Texas at Austin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cara Young, Assistant Professor, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT03600337
Other Study ID Numbers:
  • 2017-08-0024
  • 5P30NR015335
First Posted:
Jul 26, 2018
Last Update Posted:
Dec 17, 2020
Last Verified:
Dec 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2020